On Friday, Vanda Pharmaceuticals Inc. (VNDA) stock saw a modest uptick, ending the day at $4.91 which represents a slight increase of $0.17 or 3.59% from the prior close of $4.74. The stock opened at ...
Cantor Fitzgerald has recently reduced Cognition Therapeutics Inc (CGTX) stock to Neutral rating, as announced on July 30, 2024, according to Finviz. Earlier, on November 3, 2021, Oppenheimer had ...